These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28456417)

  • 1. Global economic burden of diabetes and its implications.
    Zhang P; Gregg E
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):404-405. PubMed ID: 28456417
    [No Abstract]   [Full Text] [Related]  

  • 2. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
    Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and the global burden of non-communicable disease.
    Matthews DR; Pramming S
    Lancet; 2003 Nov; 362(9397):1763-4. PubMed ID: 14643134
    [No Abstract]   [Full Text] [Related]  

  • 4. The Worldwide Burden of Diabetes. Proceedings of a workshop. Phoenix, Arizona, USA. 6-7 December 1996.
    Diabetes Care; 1998 Dec; 21 Suppl 3():C1-52. PubMed ID: 9850477
    [No Abstract]   [Full Text] [Related]  

  • 5. The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach.
    de Lagasnerie G; Aguadé AS; Denis P; Fagot-Campagna A; Gastaldi-Menager C
    Eur J Health Econ; 2018 Mar; 19(2):189-201. PubMed ID: 28190188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study on medical expenditure for diabetes mellitus and non-diabetes mellitus in 9 provinces of China, between 2000 and 2009].
    Wang HP; Hou ZY; Meng QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Sep; 34(9):911-3. PubMed ID: 24331969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluations and diabetes.
    Pathak DS; Burke TA
    Pharm Pract Manag Q; 1998 Jan; 17(4):17-24. PubMed ID: 10174745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes--a global threat.
    Lancet; 2009 May; 373(9677):1735. PubMed ID: 19465209
    [No Abstract]   [Full Text] [Related]  

  • 9. Global economic impact of diabetes.
    Nicholls M
    Eur Heart J; 2015 Jun; 36(24):1493. PubMed ID: 26295079
    [No Abstract]   [Full Text] [Related]  

  • 10. The global burden of youth diabetes: perspectives and potential.
    Aanstoot HJ; Anderson BJ; Daneman D; Danne T; Donaghue K; Kaufman F; Réa RR; Uchigata Y
    Pediatr Diabetes; 2007 Oct; 8 Suppl 8():1-44. PubMed ID: 17767619
    [No Abstract]   [Full Text] [Related]  

  • 11. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030.
    Bommer C; Sagalova V; Heesemann E; Manne-Goehler J; Atun R; Bärnighausen T; Davies J; Vollmer S
    Diabetes Care; 2018 May; 41(5):963-970. PubMed ID: 29475843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Growing Burden Of Noncommunicable Diseases.
    Weil AR
    Health Aff (Millwood); 2015 Sep; 34(9):1439. PubMed ID: 26355043
    [No Abstract]   [Full Text] [Related]  

  • 13. The economic burden of diabetes.
    Dall TM; Zhang Y; Chen YJ; Quick WW; Yang WG; Fogli J
    Health Aff (Millwood); 2010 Feb; 29(2):297-303. PubMed ID: 20075080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of diabetes to the burden of diseases].
    Wang JS; Jin SG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 May; 41(3):186-8. PubMed ID: 17708869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health promotion and disease prevention can substantially reduce the total economic burden of diabetes in the Netherlands.
    Janssen JAMJL
    Neth J Med; 2017 Sep; 75(7):263-264. PubMed ID: 28956789
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-of-illness studies in diabetes mellitus.
    Ettaro L; Songer TJ; Zhang P; Engelgau MM
    Pharmacoeconomics; 2004; 22(3):149-64. PubMed ID: 14871163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of diabetes in Iran: how will it be affected by lifting of the economic sanctions?
    Larijani B
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):810-1. PubMed ID: 27527914
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-of-illness studies of diabetes mellitus: a systematic review.
    Ng CS; Lee JY; Toh MP; Ko Y
    Diabetes Res Clin Pract; 2014 Aug; 105(2):151-63. PubMed ID: 24814877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diabetes dilemma: how do we deal with it?
    Eng PH
    Ann Acad Med Singap; 2011 Nov; 40(11):480-1. PubMed ID: 22206062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.